News
-
-
-
-
-
COMMUNIQUÉ DE PRESSE
HepaRegeniX raises €15 million Series C round to advance clinical development of HRX-215 for liver regeneration
HepaRegeniX raises €15 million Series C round led by Vesalius Biocapital IV to advance clinical development of HRX-215 for liver regeneration, appoints Elias Papatheodorou as CEO and Dr. Linda Greenbaum as CMO -
COMMUNIQUÉ DE PRESSE
Golding’s successful secondaries strategy strengthens its ESG approach and classifies as Article 8 SFDR strategy
Golding Capital Partners strengthens ESG approach with successful secondaries strategy, now an Article 8 SFDR fund. Golding Secondaries 2022 targets diverse buyout portfolio across Europe -
COMMUNIQUÉ DE PRESSE
Sa stratégie Secondaries à succès va permettre à Golding de remplir les critères de l'article 8 du règlement SFDR
Golding Capital Partners remplit les critères de l'article 8 du règlement SFDR avec sa stratégie Secondaries. Le fonds 'Golding Secondaries 2022' offre transparence ESG et diversité d'investissements -
-
COMMUNIQUÉ RÉGLEMENTÉ
Signing of a share purchase agreement with Hellenic Bank Public Company Ltd relating to its subsidiary CNP Cyprus Insurance Holdings
CNP Assurances signs agreement to sell CNP Cyprus Insurance Holdings to Hellenic Bank, enabling CIH to find new growth drivers. Transaction expected to be completed by Q1 2025 -
